Report from the European Society of Cardiology Congress 2015 in London
Journal Title: Journal of Rare Cardiovascular Diseases - Year 2015, Vol 2, Issue 4
Abstract
At least for us, the ESC Congress 2015 in London was different from the previous ones as we did not organize Satellite Symposium on rare cardiovascular diseases. It is not that we did not want to, on the contrary we tried as much as we could, but due to the fact that our EU Project MRPO 08.02.00‐12-424/10 has eventually came to an end we did not possess adequate financial back‐up to organize the session. Certainly, this is not good news for all somehow accustomed to our annual session, but on the other hand the light we torched some time ago has not been extinguished. During numerous informal meetings at the Congress we tried to cultivate what we had jointly started some time ago. As in real life, there are ups and downs and it is not difficult to carry on when everything clicks into place but real challenge is to survive even in the dark days. But now a little about the Congress itself.
Authors and Affiliations
Pawel Rubis
Keywords
Related Articles
- EP ID EP242024
- DOI 10.20418/jrcd.vol2no4.203
- Views 80
- Downloads 0
Cardiac sarcoidosis – management and prognosis (RCD code: III‑3A.3)
Sarcoidosis is a systemic, granulomatous disease of unknown etiology. Cardiac involvement in the course of sarcoidosis occurs in 5% of patients. However, about 25% of patient with systemic/pulmonary sarcoidosis might pre...
A 35-year old man with dyspnea on exertion, history of acute pulmonary embolism and ischaemic stroke
We present a case of a 35-year old man with a history of an acute pulmonary embolism and ischaemic stroke, who after several weeks of adequate antithrombotic treatment experienced functional deterioration with severe dys...
Journal of Rare Cardiovascular Diseases: Moving towards maturity, and implementing the Krakow RCD Classification as a milestone
Dear Readers – our Friends and Colleagues,The present, third, issues of your quarterly Journal of Rare Cardiovascular Diseases is an important landmark in the life of the Journal; the life that presents a process from in...
Development of the European Network in Orphan Cardiovascular Diseases. EU Project inauguration
Both international and Polish cardiology community warmly welcomed our prior international project entitled Establishing a European Network for Orphan Cardiovascular Diseases (European Regional Development Fund and Małop...
Comparison of platelet count reduction in patients with essential thrombocythaemia treated with hydroxyurea and thromboreductin. Single centre experience
Essential thrombocythemia is one of the Ph-negative myeloproliferative neoplasms treated with hydroxyurea. An alternative strategy may be a therapy with thromboreductin. The aim of the study was to compare the effectiven...